Catherine Mitchell

13PUBLICATIONS
84CO-AUTHORS
Predictive and prognostic markersMolecular targetsRadiation therapySolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.

|Mar 16, 2026
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapies.

Ciara Conduit, Bruno Valentin Sinn, Catherine Mitchell

|Dec 24, 2025
Applying Radiomics to Predict Outcomes in Patients with High-Grade Retroperitoneal Sarcoma Treated with Preoperative Radiotherapy.

Adel Shahnam, Nicholas Hardcastle, David E Gyorki

|Nov 11, 2025
Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory.

Adel Shahnam, Catherine Mitchell, Christopher R McEvoy

|Oct 29, 2025
Survival Outcomes and Prognostic Factors in Metastatic Unresectable Appendiceal Adenocarcinoma Treated with Palliative Systemic Chemotherapy: A 10-Year Retrospective Analysis from Australia.

Jirapat Wonglhow, Hui-Li Wong, Michael Michael

|Jul 10, 2025
Defining an Unresectable Primary Retroperitoneal Sarcoma.

James Tai, Eyal Mor, Catherine Mitchell

Pageof 3

Frequent Collaborators

2 joint publications

Alexander Heriot

2 joint publications

Joseph H A Vissers

2 joint publications

Eyal Mor

1 joint publications

King Tung Cheung